Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Joinn Laboratories(China)Co
603127Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China. Address: A5 Rongjing East Street, Beijing, China, 100176
Analytics
Zielpreis von Wall Street
98.22 CNYKGV
–Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 603127
Dividenden-Analyse 603127
Dividendenwachstum über 5 Jahre
617 %Kontinuierliches Wachstum
5 JahreAusschüttungsquote 5-Jahres-Durchschnitt
24 %Verlauf der Dividende 603127
Bewertung der Aktie 603127
Finanzen 603127
Ergebnisse | 2019 | Dynamik |